Stock screenerAll disclosures →
EDGAR →
AGEN
Conviction 92HealthcareScan · Mon, Aug 10, 2026Hanging man
AGEN$7.01+0.72%
ResistanceSupportVol 14Vol MA14 3.62M
May 11May 28Jun 16Jul 6Jul 23Aug 10
WSB mentions · 24h changelatest -66.67%· 2 mentions
May 11May 28Jun 16Jul 6Jul 23Aug 10
Price7.01
Change+0.72%
Gap-1.80%
Rel volume2.35×
Avg volume3.77M
Avg $ vol24.11M
SMA 206.42
SMA 504.56
SMA 2003.88
Price vs 50+53.86%
Price vs 200+80.60%
MA stackbullish
50/200 cross—
Supertrendup · 5.99
RSI (14)60
MACD hist-0.03
MACD crossbear · 0d
Stoch %K / %D46 / 54
ADX (14)61
+DI / −DI32 / 14
RSI divergenceBearish
MACD divergence—
ATR %+10.28%
ADR %11.29%
52w high8.30
52w low2.77
From 52w high-15.54%
Above 52w low+153.07%
New 52w highNo
SqueezeOff
Bollinger width68.65%
%B0.63
Donchian pos56.14%
Donchian high8.85
Donchian low4.66
AVWAP (52w high)6.93
vs AVWAP high+1.16%
AVWAP (52w low)5.80
vs AVWAP low+20.95%
OBV trendUp
Chaikin MF (20)0.18
Today vs 20d2.35×
Avg vol (14d)3.62M
Avg vol (20d)3.77M
Avg $ vol (20d)24.11M
Market cap315.59M
RS 3m (vs SPY)+79.90%
RS 6m (vs SPY)+137.15%
RS line new highNo
Trend template6/8
Technical rank89.8
1 week-10.36%
1 month+109.25%
3 months+83.51%
6 months+138.44%
1 year+47.27%
YTD+117.03%
P/E-2.61
P/B-1.59
P/S2.76
P/FCF-4.09
EPS0.0000
Div yield—
ROE60.63%
ROA-69.89%
Debt/Eq-0.15
Current0.34
EV/EBITDA-32.15
Gross margin—
Net margin-105.69%
Rev growth10.37%
EPS growth4.96%
Price target22.00
Target upside213.84%
Analyst ratingBuy
Institutional35.30%
Ent. value326.92M
Revenue34.52M
Net income-33.73M
Gross profit—
Free cash flow-77.2M
IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
ExchangeNasdaq
Shares out41.64M
Employees81
ListedFri, Feb 4, 2000
Free float35.54M
Float %92.6%
Short interest7.06M
Days to cover0.4d
Short volume56.4%
Squeeze score68 / 100
Next earnings—
EPS forecast—
Last EPS vs est−$0.01 vs $0.05
Last surprise-120.0% miss
Setup gradeA+
Conviction92 / 100
Pattern quality—
Tech rank89.8 / 100
Group rank86 / 100 · Leading
Status lane—
Setup direction—
Pattern family
Resistance—
Support—
Days since event—
Candle confirmHanging man
News sentiment—
Financials as of Sun, Sep 30, 2018 · quarterly.
Congress activity
Disclosed STOCK Act trades in AGEN
No recent disclosed trades by Congress in AGEN. STOCK Act filings can lag the trade by up to 45 days.
Insider activity
SEC Form 4 transactions in AGEN · 9 buys
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
Buell Jennifer See Remarks · Stock Option · 2026-08-05 | Grant | 200K | — | 2026-08-05 | 2026-08-07 |
Hirsch Susan B Director · Stock Option · 2026-08-05 | Grant | 50K | — | 2026-08-05 | 2026-08-07 |
O'Day Steven J Chief Medical Officer · Stock Option · 2026-08-05 | Grant | 100K | — | 2026-08-05 | 2026-08-07 |
Wright Timothy Director · Stock Option · 2026-08-05 | Grant | 50K | — | 2026-08-05 | 2026-08-07 |
Wright Timothy Director · Deferred Stock Units · 2026-07-01 | Grant | 2.27K | — | 2026-07-01 | 2026-07-07 |
HARRISON THOMAS L Director · Common Stock · 2026-07-01 | Grant | 8.55K | $31K | 2026-07-01 | 2026-07-07 |
ARMEN GARO H See Remarks · Common Stock · 2026-06-26 | Grant | 5.36K | $16K | 2026-06-26 | 2026-06-30 |
ARMEN GARO H See Remarks · Common Stock · 2026-06-12 | Grant | 4.92K | $16K | 2026-06-12 | 2026-06-16 |
ARMEN GARO H See Remarks · Common Stock · 2026-05-29 | Grant | 4.64K | $16K | 2026-05-29 | 2026-06-02 |
ARMEN GARO H See Remarks · Common Stock · 2026-05-29 | Other | — | — | 2026-05-29 | 2026-06-02 |
SEC filings
EDGAR filings in AGEN · 10 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.
Start free — 14-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.